| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |